AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Address Medical. Under this agreement, Address Medical is authorized to distribute AliveDx’s MosaiQ® and LumiQ® solutions in United Arab Emirates.
This partnership represents another important milestone in AliveDx’s strategy to expand its footprint in key emerging markets and to support healthcare providers with innovative, high-value diagnostic technologies. Through this collaboration, AliveDx and Address Medical aim to enhance access to advanced diagnostics, helping clinicians shorten time to diagnosis and improve patient outcomes.
Transforming Diagnostics with MosaiQ® & LumiQ®
The MosaiQ® and LumiQ® platforms are designed to streamline laboratory workflows and increase operational efficiency through fully automated, multiplex microarray assay technology. These solutions enable laboratories to deliver faster, more cost-effective, and high-quality diagnostic results, benefiting both healthcare professionals and patients.
“We are pleased to partner with Address Medical, a trusted and dynamic organization in the healthcare sector. This agreement reinforces AliveDx’s commitment to working with strong local partners to bring cutting-edge diagnostic solutions closer to clinicians and patients,” said Manuel O. Méndez, CEO of AliveDx.
“Expanding our partnerships with capable and forward-looking organizations like Address Medical is central to our Emerging Markets strategy. We look forward to working closely together to drive adoption of advanced autoimmune diagnostics and to create meaningful clinical and economic value for healthcare providers,” said Khaled Hamed, Head of Global Emerging Markets, AliveDx.
About Address Medical
Address Medical is a healthcare solutions provider focused on delivering high-quality medical and diagnostic technologies to healthcare institutions. With a strong emphasis on service excellence and long-term partnerships, Address Medical supports laboratories and healthcare providers in adopting advanced solutions that improve efficiency and patient care.
“We are proud to partner with AliveDx and to add the MosaiQ® and LumiQ® platforms to our diagnostic portfolio. These innovative solutions align well with our commitment to providing advanced, reliable technologies that support better clinical decision-making and improved patient outcomes,” said Ussama Kupparayil, General Manager, Address Medical.
Visit our websites to learn more:
